Transpek Industry Ltd (TRANSPEK) — concall transcript | 31 December 2024

Transpek Industry Limited reported 12% YoY revenue growth to Rs. 505.6 crores for 9 months FY25, with EBITDA up 7.6% to Rs. 90.3 crores excluding a one-time Rs. 6.9 crore write-off, though EBITDA margin declined 70 basis points to 17.9%. PAT fell 10.4% to Rs. 29.5 crores amid a shift toward higher-margin specialty chemicals, which now contribute Rs. 30-35 crores run-rate versus Rs. 82 crores annually in FY24. The company emphasized cautious capex deployment, targeting 20-23% margins from new products like Kevlar EXO, with commercial production slated for January 2026. International revenue dominates at 86%, led by North America (62%), while new customer acquisitions in US, South America, Japan, and Eurasia signal expansion. Capacity stands at Rs. 900 crores with 65% utilization, and NSE listing procedures are underway for completion by April 2025.